Mylan, Par win rights to sell knockoff Silenor; Meta-analysis backs withdrawn Lilly sepsis drug;

 @FiercePharma: Humira sales growth helped fuel Abbott's Q2 revenues. $2.3 billion. Good for spinoff if it continues. More | Follow @FiercePharma

> Mylan ($MYL) and Par Pharmaceuticals ($PRX) settled their patent fights with Somaxon Pharmaceuticals over Silenor, agreeing to launch dates in 2020. Report

> A new meta-analysis from The Lancet suggests that Eli Lilly's ($LLY) withdrawn sepsis drug Xigris may be more beneficial than previously thought. Report (reg. req.)

> An Australian drug distributor, Diageo, agreed to pay "a multimillion-dollar amount" to a patient born without arms or legs after her mother used thalidomide during pregnancy. Report

> Federal prosecutors charged four dozen people in a $108 million Medicaid fraud scheme, saying the ring diverted drugs for Medicaid recipients to black-market sales. Report

> The state of Georgia delayed an execution to next week to enable a switch from a lethal injection cocktail of three drugs to just one, pentobarbital. Report

> The Obama Administration's mandate that insurers provide contraceptives free of charge survived a federal-court challenge by 7 states. Report

> The European Commission earmarked 4.3 million euros to help 700 laid-off AstraZeneca ($AZN) workers in Sweden transition to new jobs. Report

Biotech News

 @FierceBiotech: Boehringer backs study of ‪mobile‬ ‪diabetes‬ care. Story | Follow @FierceBiotech

 @JohnCFierce: Buzz: Big investors likely to back next wave of biotech buyouts. Report | Follow @JohnCFierce

 @RyanMFierce: I sense a micro tech bubble forming in ‪genomic‬ data interpretation, annotation software. I see a new company in this space every month or so. | Follow @RyanMFierce

> GSK boosts stake in Amicus as PhIII Fabry data looms. Article

> FDA hits green light on Vivus weight drug Qnexa. News

> Amag preps sNDA after Feraheme clears PhIII hurdles. Item

Medical Device News

@FierceMedDev: Teleflex says it's buying catheter firm Hotspur for $15M and selling off its ortho unit for $45M. Item | Follow @FierceMedDev

 @MarkHFierce: St. Jude's Medical's Q2 earnings disappoint. Story | Follow @MarkHFierce

 @DamianFierce: Steris is buying U.S. Endoscopy for $270M in cash. More | Follow @DamianFierce

> Mindray seals $35M deal for Dragonbio's orthopedics implant line. More

> Abbott's Dx investment pays off with Q2 growth. Story

Drug Delivery News

> Ex-Sanofi exec joins Kala as President and CEO. Story

> Tekmira's technology delivers Alnylam Phase I RNAi results. Article

> Tea leaves could deliver prostate cancer treatment. More

> Microparticles deliver vaccines to the gut. Item

> NuPathe stock climbs on migraine patch resubmission. News

Biomarkers News

> The ethics of Alzheimer's risk testing. Report

> Genetic biomarkers tag antipsychotic weight gain. Article

> U.S. researchers gain $6.5 M grant to smoke out COPD markers. News

> Markers map slide into Alzheimer's. More

> Biomarkers could make multiple sclerosis diagnosis easier. Story

> DeCode, Genentech find gene mutation marks protection against Alzheimer's. Article

> Gold stars in ultrasensitive biomarker test. Item

And Finally... The latest U.S. export: a sedentary lifestyle, and the expanding waistline that comes with it. Report